We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

40 hedge funds and large institutions have $289M invested in Heron Therapeutics in 2014 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,700% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 1

2,646% more capital invested

Capital invested by funds: $10.5M → $289M (+$279M)

1,233% more funds holding

Funds holding: 3 → 40 (+37)

500% more funds holding in top 10

Funds holding in top 10: 1 → 6 (+5)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
40
Holders Change
+37
Holders Change %
+1,233.33%
% of All Funds
1.16%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.17%
New
38
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$58.9M
2
Franklin Resources
Franklin Resources
California
+$43.4M
3
BC
Broadfin Capital
New York
+$29.8M
4
BBA
Baker Bros. Advisors
New York
+$29M
5
SC
Savitr Capital
California
+$24.8M

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$445K
2
VM
VHCP Management
New York
-$13
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$234K +$224K +16,803 New
CS
27
Credit Suisse
Switzerland
$231K +$222K +16,600 New
LP
28
LMR Partners
United Kingdom
$200K +$192K +14,367 New
BCMU
29
BlueCrest Capital Management (UK)
Guernsey
$192K +$184K +13,800 New
TC
30
TFS Capital
Pennsylvania
$190K +$182K +13,651 New
State Street
31
State Street
Massachusetts
$173K +$166K +12,400 New
Deutsche Bank
32
Deutsche Bank
Germany
$44K +$42.9K +3,213 New
TC
33
TradeLink Capital
Illinois
$17K +$16K +1,200 New
TRCT
34
Tower Research Capital (TRC)
New York
$16K +$15K +1,123 New
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$8K +$7.75K +580 New
CG
36
Colony Group
Massachusetts
$2K +$1.91K +143 New
AIG
37
American International Group
New York
$1.67K +$1.6K +120 New
Citigroup
38
Citigroup
New York
$1K +$922 +69 New
Wells Fargo
39
Wells Fargo
California
$1K +$1.34K +100 New
WEC
40
Winslow Evans & Crocker
Massachusetts
$14 +$13 +1 New
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
– -$445K -50,000 Closed
1
2

HRTX Hedge Fund Activity: Q1 2014 in Review

40 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2014, worth a combined $289M — up 2,646% from $10.5M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new HRTX positions and 1 closed out — a net gain of 37 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $58.9M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $445K sold.

  • 40 institutional investors held Heron Therapeutics (HRTX) as of Q1 2014, up from 3 in Q4 2013.
  • Funds reported $289M of Heron Therapeutics stock for Q1 2014, up 2,646% quarter-over-quarter.
  • 38 funds opened new Heron Therapeutics positions in Q1 2014 and 1 closed out, a net change of +37 holders.
  • The largest Heron Therapeutics buyer in Q1 2014 was Tang Capital Management, an estimated $58.9M added.
  • The largest Heron Therapeutics seller in Q1 2014 was Alyeska Investment Group, an estimated $445K sold.

Based on aggregated 13F filings for Q1 2014.